---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-008981"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2025-03-24T23:59:59+00:00"
generated_at: "2026-05-24T07:49:17.243964+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Windtree raises $250K via secured notes, licenses Phexxi supply rights, regains Nasdaq compliance

## Summary
- Issued $312,500 principal in senior secured notes at 10% interest, due March 2026, with 20% OID; net proceeds $250,000.
- Entered license and supply agreement with Evofem to manufacture and supply Phexxi outside the U.S. for an initial three-year term.
- Regained compliance with Nasdaq minimum bid price rule (closing bid >$1.00 since Feb 21, 2025); subject to panel monitor until March 20, 2026.
- Notes secured by first-priority lien on all assets; mandatory redemption of 30% of equity line proceeds if equity line is used.

## SEC filing metadata
- accession: 0001437749-25-008981
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2025-03-24T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774925008981/0001437749-25-008981-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774925008981/wint20250323_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-008981
- JSON: https://secwatch.observer/filing/0001437749-25-008981.json
- Plain text: https://secwatch.observer/filing/0001437749-25-008981.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.